Evidence map›Paper›PMID 39281284›Full record

ArticleFrontiers in pharmacology2024

Multiple site inflammation and acute kidney injury in crush syndrome.

Hiroaki Miyauchi, Koshu Okubo, Kiriko Iida, Hiroshi Kawakami, Kentaro Takayama, Yoshio Hayashi, Junji Haruta, Junichi Sasaki, Kaori Hayashi, Junichi Hirahashi

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hiroaki Miyauchi *Department of General Medicine Education, School of Medicine, Keio University, Tokyo, Japan.
Koshu Okubo *Department of General Medicine Education, School of Medicine, Keio University, Tokyo, Japan.
Kiriko IidaDivision of Food and Nutrition, Graduate School of Human Sciences, Kyoritsu Women's University, Tokyo, Japan.
Hiroshi KawakamiDivision of Food and Nutrition, Graduate School of Human Sciences, Kyoritsu Women's University, Tokyo, Japan.
Kentaro TakayamaDepartment of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Yoshio HayashiDepartment of Medicinal Chemistry, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Junji HarutaDepartment of General Medicine Education, School of Medicine, Keio University, Tokyo, Japan.
Junichi SasakiDepartment of General Medicine Education, School of Medicine, Keio University, Tokyo, Japan.
Kaori HayashiDepartment of Endocrinology, Metabolism and Nephrology, School of Medicine, Keio University, Tokyo, Japan.
Junichi HirahashiDepartment of General Medicine Education, School of Medicine, Keio University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crush syndrome, which frequently occurs in earthquake disasters, often leads to rhabdomyolysis induced acute kidney injury (RIAKI). Recent findings indicate that systemic inflammatory response syndrome (SIRS) exacerbates muscle collapse, contributing to RIAKI. The purpose of this study is to investigate the involvement of multiple site inflammation, including intraperitoneal, in crush syndrome. In a mouse model of RIAKI, elevated levels of inflammatory mediators such as TNFα, IL-6, myoglobin, and dsDNA were observed in serum and the peritoneal cavity, peaking earlier in the intraperitoneal cavity than in serum or urine. Our previously developed novel peptide inhibiting leukocyte extracellular traps was administered intraperitoneally and blocked all of these mediators in the intraperitoneal cavity and serum, ameliorating muscle damage and consequent RIAKI. Although further studies are needed to determine whether intraperitoneal inflammation associated with muscle collapse can lead to systemic inflammation, resulting in more severe and prolonged muscle damage and renal injury, early suppression of multiple site inflammation, including intraperitoneal, might be an effective therapeutic target.

Indexed as

crush syndromeintraperitoneal inflammationkidney injurymacrophage extracellular trapmuscle damagerhabdomyolysissystemic inflammatory response syndrome

Identifiers

PMID39281284
PMCPMC11392879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.